Core Viewpoint - Movano Inc. and Corvex, Inc. have announced a definitive agreement for an all-stock merger, positioning Corvex to enter public markets and enhance its AI infrastructure capabilities [1][4]. Company Overview - Corvex specializes in AI cloud computing with a focus on GPU-accelerated infrastructure for AI workloads, led by co-founders Seth Demsey and Jay Crystal [3]. - Movano, known for its healthcare solutions, will be renamed Corvex, Inc. post-merger, with headquarters in Arlington, Virginia [5]. Merger Details - The merger will allow Corvex to leverage Movano's existing assets and market presence, with a merger exchange ratio based on a Movano per share value of $6.25 [4][7]. - Corvex shareholders will receive approximately 46.6 million shares of Movano stock, resulting in pre-merger Corvex stockholders owning about 96.2% of the combined company [7]. Financial Aspects - Corvex has raised $37.1 million in equity capital through a private placement, while Movano has secured a $1.0 billion equity facility and raised an additional $3.0 million [6]. - The combined company is expected to have around 48.7 million shares outstanding post-merger [7]. Strategic Positioning - The merger aims to capture the growing demand for AI infrastructure, with a focus on delivering GPU-as-a-Service and AI-as-a-Service capabilities [2][4]. - The leadership team brings extensive experience from major tech firms, enhancing the combined company's operational capabilities [5]. Product Offerings - Corvex's product suite includes AI factories, confidential computing, and inference-as-a-service, designed to support AI model training and inference at scale [9]. - The platform emphasizes security and efficiency, catering to the needs of AI innovators [2][9]. Future Plans - Movano Health will continue to market its medical device operations, including the FDA-cleared EvieMED Ring, while the combined company will focus on expanding its AI infrastructure offerings [4][8].